Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

858

Participants

Timeline

Start Date

October 21, 2013

Primary Completion Date

January 2, 2018

Study Completion Date

February 15, 2022

Conditions
Breast CancerSurgery
Interventions
PROCEDURE

SLN detection +/- complementary axillary lymphadenectomy

breast cancer surgery with SLN detection +/- complementary axillary lymphadenectomy Whatever the detection method used in the lab (Arm A: OSNA; Arm B: Pathological Examination; Arm C: Extemporaneous) to assess the positivity of sentinel lymph-node invasion, if negative result (no tumor invasion in the sentinel LN), a complementary lymph-node dissection is not mandatory if positive result (tumor invasion in the sentinel LN), a complementary lymph-node dissection is performed, either immediately (Arm A and C) or in a second surgical procedure (Arm B)

Trial Locations (17)

13009

Institut Paoli Calmettes, Marseille

31052

IUCT-O, Toulouse

33000

Institut Bergonie, Bordeaux

42013

Clinique Mutualiste, Saint-Etienne

42277

CHU, Saint-Priest-en-Jarez

44800

Jean-Marc cancérologie CLASSE, Saint-Herblain

49000

ICO Paul Papin, Angers

54511

Institut de Cancérlogie de Lorraine, Vandœuvre-lès-Nancy

59552

Institut du Sein -Clinique Saint-Amé, Lambres-lez-Douai

63011

Jean Perrin, Clermont-Ferrand

69495

CHU, Pierre-Bénite

75015

HEGP, Paris

75248

Institut Curie, Paris

76038

Henri BECQUEREL, Rouen

92210

Institut Curie, Saint-Cloud

Unknown

Oscar Lambret, Lille

Eugène Marquis, Rennes

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT02056886 - Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer | Biotech Hunter | Biotech Hunter